Published in Drug Week, February 11th, 2005
Published in the January 11, 2005 issue of the journal Vaccine, the paper is entitled "Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans." The authors conclude that Vaxin's novel flu vaccine, which is produced in cell culture, was immunogenic and well-tolerated by human volunteers.
"To our knowledge, this represents the first report of a recombinant influenza vaccine using a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.